- Human Leukocyte Antigen-Specific Antibodies and Gamma-Interferon Stimulate Human Microvascular and Glomerular Endothelial Cells to Produce Complement Factor C4
[作者:Hamer, R; Molostvov, G; Lowe, D; Satchell, S; Mathieson, P; Ilyas, R; Mitchell, DA; Lam, FT; Kashi, H; Tan, LC; Imray, C; Fletcher, S; Briggs, D; Krishnan, N; Higgins, R; Zehnder, D,期刊:Transplantation, 页码:867-873 , 文章类型: Article,,卷期:2012年93-9]
- Background. The role of the complement system in antibody-mediated rejection has been investigated in relation to circulating complement interacting with renal microvascular endothelium, resulting in the formation of per...
- Sirolimus-Associated Testicular Toxicity: Detrimental But Reversible
[作者:Rovira, J; Diekmann, F; Ramirez-Bajo, MJ; Banon-Maneus, E; Moya-Rull, D; Campistol, JM,期刊:Transplantation, 页码:874-879 , 文章类型: Article,,卷期:2012年93-9]
- Background. Mammalian target of rapamycin (mTOR) inhibition has been associated with gonadal dysfunction. The aim of this study was to characterize the effect of sirolimus (SRL) on male gonadal function in an experimenta...
- The Hepatic Soluble Guanylyl Cyclase-Cyclic Guanosine Monophosphate Pathway Mediates the Protection of Remote Ischemic Preconditioning on the Microcirculation in Liver Ischemia-Reperfusion Injury
[作者:Abu-Amara, M; Yang, SY; Quaglia, A; Rowley, P; Tapuria, N; Fuller, B; Davidson, B; Seifalian, A,期刊:Transplantation, 页码:880-886 , 文章类型: Article,,卷期:2012年93-9]
- Background. Remote ischemic preconditioning (RIPC) protects against liver ischemia reperfusion (IR) injury. An essential circulating mediator of this protection is nitric oxide (NO) induced by lower limb RIPC. One of the...
- Randomized Trial Comparing Late Concentration-Controlled Calcineurin Inhibitor or Mycophenolate Mofetil Withdrawal
[作者:Mourer, JS; den Hartigh, J; van Zwet, EW; Mallat, MJK; Dubbeld, J; de Fijter, JW,期刊:Transplantation, 页码:887-894 , 文章类型: Article,,卷期:2012年93-9]
- Background. Early calcineurin inhibitor (CNI) withdrawal with mycophenolate mofetil (MMF) has not become routine practice, due to concerns about excess acute rejection. Therapeutic drug monitoring may be advantageous whe...
- Impact of Conversion to a Once Daily Tacrolimus-Based Regimen in Kidney Transplant Recipients With Gastrointestinal Complications
[作者:Veroux, M; Grosso, G; Ekser, B; Corona, D; Giaquinta, A; Veroux, P,期刊:Transplantation, 页码:895-899 , 文章类型: Article,,卷期:2012年93-9]
- Background. Gastrointestinal (GI) complications may affect up to 64% of kidney transplant recipients, with a higher incidence of symptoms in patients receiving tacrolimus-based immunosuppression. Tacrolimus extended rele...
- Association of Genetic Polymorphisms of Interleukins With New-Onset Diabetes After Transplantation in Renal Transplantation
[作者:Kim, YG; Ihm, CG; Lee, TW; Lee, SH; Jeong, KH; Moon, JY; Chung, JH; Kim, SK; Kim, YH,期刊:Transplantation, 页码:900-907 , 文章类型: Article,,卷期:2012年93-9]
- Background. New-onset diabetes after transplantation (NODAT) is a serious metabolic complication. Although A-cell dysfunction is considered the main contributing factor in the development of NODAT, the precise pathogenes...
- Repeat True Surveillance Biopsies in Kidney Transplantation
[作者:Buchmann, TN; Wolff, T; Bachmann, A; Guerke, L; Steiger, J; Mihatsch, MJ; Dickenmann, M,期刊:Transplantation, 页码:908-913 , 文章类型: Article,,卷期:2012年93-9]
- Background. Protocol biopsies are assigned to fixed points in time after transplantation irrespective of renal function. Usually, it is not known whether there is graft dysfunction at the time of biopsy. This study analy...
- Anogenital Malignancies in Women After Renal Transplantation Over 40 Years in a Single Center
[作者:Meeuwis, KAP; Melchers, WJG; Bouten, H; van de Kerkhof, PCM; Hinten, F; Quint, WGV; Massuger, LFAG; Hoitsma, AJ; van Rossum, MM; de Hullu, JA,期刊:Transplantation, 页码:914-922 , 文章类型: Article,,卷期:2012年93-9]
- Background. Renal transplant recipients have an increased risk to develop human papillomavirus (HPV)-related anogenital malignancies. A clinical overview of female anogenital posttransplantation malignancies and possible...
- Anemia After Kidney Transplantation; Its Prevalence, Risk Factors, and Independent Association With Graft and Patient Survival: A Time-Varying Analysis
[作者:Jones, H; Talwar, M; Nogueira, JM; Ugarte, R; Cangro, C; Rasheed, H; Klassen, DK; Weir, MR; Haririan, A,期刊:Transplantation, 页码:923-928 , 文章类型: Article,,卷期:2012年93-9]
- Introduction. Posttransplant anemia and its association with transplant outcomes have not been properly studied. Methods. We examined 530 renal allograft recipients transplanted at our center and followed up for 31.0 +/-...
- V5-Drainage-Preserved Right Lobe Grafts Improve Graft Congestion for Living Donor Liver Transplantation
[作者:Toshima, T; Taketomi, A; Ikegami, T; Fukuhara, T; Kayashima, H; Yoshizumi, T; Soejima, Y; Shirabe, K; Maehara, Y,期刊:Transplantation, 页码:929-935 , 文章类型: Article,,卷期:2012年93-9]
- Background. Right lobe (RL) grafts without middle hepatic vein for living donor liver transplantation (LDLT) result in congestion of recipients' livers and sometimes in unfavorable postoperative course. This study aimed ...
- Anti-Human Leukocyte Antigen Immunization After Early Allograft Nephrectomy
[作者:Del Bello, A; Congy, N; Sallusto, F; Cardeau-Desangles, I; Fort, M; Esposito, L; Guitard, J; Cointault, O; Lavayssiere, L; Nogier, MB; Game, X; Blancher, A; Rostaing, L; Kamar, N,期刊:Transplantation, 页码:936-941 , 文章类型: Article,,卷期:2012年93-9]
- Introduction. The occurrence of de novo anti-human leukocyte antigen (HLA) antibodies and donor-specific antibodies (DSAs) after early graft loss is not well known. The aims of this single-center study were to evaluate t...
- Donor Morbidity Including Biliary Complications in Living-Donor Liver Transplantation: Single-Center Analysis of 827 Cases
[作者:Shin, M; Song, S; Kim, JM; Kwon, CHD; Kim, SJ; Lee, SK; Joh, JW,期刊:Transplantation, 页码:942-948 , 文章类型: Article,,卷期:2012年93-9]
- Background. Because of the shortage of deceased-donor livers for transplantation, living-donor liver transplantation (LDLT) has become an indispensible treatment strategy for end-stage liver disease. The critical prerequ...
- Distinct Oligoclonal T Cells Are Associated With Graft Versus Host Disease After Stem-Cell Transplantation
[作者:Berrie, JL; Kmieciak, M; Sabo, RT; Roberts, CH; Idowu, MO; Mallory, K; Chung, HM; McCarty, JM; Borrelli, CA; Detwiler, MM; Kazim, AL; Toor, AA; Manjili, MH,期刊:Transplantation, 页码:949-957 , 文章类型: Article,,卷期:2012年93-9]
- Background. In patients with hematologic malignancies who receive stem-cell transplantation, donors' T cells can recognize minor histocompatibility antigens on recipient cells and generate an objective response against t...
|